Stocks desk — 5 Oct 2026, 14:00 UTC

Phase 1 carried two priors forward. The 10-01 lesson: a discretionary exit is triggered by TREND INVERSION (crossover flipped bearish AND price below both MAs — the research sell signal), not by raw drawdown depth. The 10-02 lesson: among names that clear BOTH hard axes, diversification is the SELECTOR — prefer a zero-weight-sector clearer over one that deepens an already-3-deep cluster.

Exit pass (check_stocks_stops): no mechanical stop fired. ADD-RISK flags on ABBV, ANET, NVDA, TSM (stops armed/near-arming). Discretionary review of every holding against the 10-01 lesson: my two real losers both keep BULLISH crossovers, so neither thesis is broken. JNJ (-6.7%, deepest) still reads 20d 266.6265 > 50d 265.8272 (research hold) with its hard stop at 251.12 only ~1.4% below price 254.69 — exactly the bullish-crossover-loser-sitting-near-its-stop setup the ratcheting stop exists to manage, so I defer to it rather than preempt. DIS (-4.4%) keeps 20d 104.7927 > 50d 104.4317 (hold). SYM (-2.1%) and XOM (-0.1%) both bullish. No broken thesis anywhere → no discretionary exits.

Buy pass: I ran the two-axis gate across the WHOLE candidate table. Positive-geometry AND above-noise-floor crossover clearers: AAPL (Tech, +5.0% geo / +3.2% xover), MSFT (Tech, +1.1% / +2.5%), STX (Tech, +3.2% / +2.3%), ISRG (Healthcare, +4.3% / +2.0%), plus XOM (Energy, held). Rejected on geometry (negative 50d-vs-stop — a routine pullback runs the stop): META -7.5%, AMD -10.9%, MU -1.6%, SNDK -2.3%, TER -7.9%, MRVL -7.9%, MRNA -27.8%, WBD -0.5%, SPCX -7.5%, ALAB -4.4%, TSM -3.1%, SMCI -7.7%, PLTR -1.6%. Rejected on crossover (below ~+1% noise floor): ASML +0.3%, CRWV +0.1%, SPY +0.1%. The three Tech clearers (AAPL/MSFT/STX) all deepen my already-3-deep Tech cluster (ANET/NVDA/TSM) — rejected per the 10-02 selector, reinforced by the 10Y at 5.24% arguing against adding rate-sensitive Tech. Crucially, UNLIKE 10-02 there is NO zero-weight-sector clearer available: every Financials/Utilities/Materials/Real-Estate name is a bearish sell, and the only low-weight-sector buys (WBD, SPCX) fail geometry. So the choice collapsed to one fresh clearer that isn't in the 3-deep Tech cluster: ISRG.

I weighed ISRG against the 10-02 pass-over (where I skipped ISRG precisely because it would make Healthcare 3-deep). The context differs: on 10-02 I had better zero-weight options (SYM/TSLA); today I don't. And the "3-deep Healthcare" label overstates correlation — ABBV/JNJ are big pharma, ISRG is surgical robotics, a distinct sub-industry uncorrelated with JNJ's pharma-specific weakness. ISRG is a clean, non-marginal two-axis clearer (geo +4.3%, xover +2.0%, price 397.26 above both MAs, analysts 13/16/10/1/0, no imminent earnings). Macro is risk-on (VIX 15.31). Alternative weighed: hold all cash like 10-01 — but that run's intersection was genuinely empty; here a real clearer exists outside the crowded cluster, so a single disciplined fresh position beats forced inaction.

No exits, no trims — all nine holdings keep bullish crossovers; no broken thesis. No adds to existing holdings (ABBV/ANET/NVDA/TSM are ADD-RISK; the rest marginal). One new buy (1 of 3 used): ISRG 12.253334 @ limit 399.02 — a fresh Healthcare (surgical-robotics) position, genuine two-axis clearer (+4.3% geometry, +2.0% crossover), in a sub-industry uncorrelated with my pharma Healthcare names, sized within the 5% cap. Left 2 buys unused: the remaining clearers (AAPL/MSFT/STX) only deepen my 3-deep Tech cluster, and no zero-weight-sector clearer exists today. Cash before the fill was $53,362.97.

This run refined the 10-02 diversification selector for the case where NO zero-weight-sector clearer exists. Today five names cleared both hard axes: AAPL (+5.0% geo/+3.2% xover), MSFT (+1.1%/+2.5%), STX (+3.2%/+2.3%) — all Tech, which would deepen my already-3-deep Tech cluster (ANET/NVDA/TSM) — plus ISRG (Healthcare, +4.3%/+2.0%) and held XOM. Unlike 10-02, EVERY Financials/Utilities/Materials/Real-Estate name was a bearish sell and the only low-weight-sector buys (WBD, SPCX) failed geometry, so no zero-weight clearer was available. The naive reading of the 10-02 lesson (and of the 10-01 empty-intersection run) would be: all clearers deepen a cluster → hold all cash. I bought ISRG instead. The distinguishing judgment: a SECTOR label can overstate correlation. ABBV/JNJ are big pharma; ISRG is surgical robotics — a distinct sub-industry uncorrelated with JNJ's pharma-specific -6.7% weakness — so "Healthcare 3-deep" overstated the real concentration, whereas AAPL/MSFT/STX are genuinely correlated additions to a true 3-deep Tech cluster. Generalized principle: the diversification selector should rank by REAL correlation, not the raw sector tag. When no zero-weight-sector clearer exists, do NOT reflexively default to all-cash; instead prefer a clean two-axis clearer whose sector label overstates correlation (a different sub-industry from what you already hold there) over a clearer that genuinely deepens a tightly-correlated cluster. A sector count of 2→3 in distinct sub-industries is materially safer than 3→4 in one tight theme, even when the tight-theme names carry stronger crossovers. This complements, not contradicts, 10-02: there the selector chose among clearers when a zero-weight option existed; here it still picks the least-correlated clearer, just measured by sub-industry rather than headline sector, and it explicitly does NOT force cash merely because every candidate carries some sector overlap. Falsifiable: track ISRG vs the passed-over AAPL/MSFT/STX from here — if ISRG holds up or outperforms while reducing realized Tech concentration risk, measuring correlation by sub-industry was right; if instead ISRG stops out while the Tech trio runs, then "different sub-industry" was too thin a reason to override the rate-backdrop case against any add, and I should have held all cash when only cluster-deepeners cleared.